AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Mpact DM France

Recruitingn/aAges 18 Years - 80 YearsAllMedacta International SA
💬

In plain words

What the trial is, and whether it could suit you

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patient with a disease that meets the indications for use of Medacta implants (according to the instructions for use) 2. Patient eligible for first-line total hip replacement 3. Patient between 18 and 80 years of age 4. Patient covered by the Social Security system or an equivalent protection plan 5. Patient who is capable, in the opinion of the investigator, of fulfilling the requirements of the study Exclusion Criteria: 1. Patient requiring a transplant 2. Patient with progressive local or systemic infection 3. Patient with muscle loss, neuromuscular disease, or vascular impairment of the affected limb making surgery unwarranted 4. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg/m². 6. Patient with major cognitive problems that do not allow a good understanding of the study requirements 7. Patient living in a geographical area that does not allow the study follow-up 8. Patient participating in interventional research. 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code 12. Pregnant or nursing woman.
💊

What it tests

  • Not listed
📍

Where

1 site
Centre Orthopédique Médico-Chirurgical de Dracy Le Fort
Dracy-le-Fort, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy